glp-1 receptors in the brain From metabolism to mind: expanding role of the receptor neurotherapeutics Interaction between GLP-1 signaling and

[51,68, 69, 70, 71, 72] Liraglutide (Saxenda ) is the first GLP-1RA therapeutic agent being approved by FDA for adults and adolescents (ages 12) with obesity or overweight and comorbidities

doi: 10.1515/mr-2024-0052

Simultaneous use of NSAIDs (for example ibuprofen) was associated with better responsiveness in women under 40

Obesity-drug pioneers win prestigious Lasker Award for medical science

[76] Several clinical trials on additional GLP-1-based agents including triple agonists (Retatrutide), [77] oral formation (Orforglipron), [78] and combination therapy (CagriSema) are in the late phase of trials

Eighty-two percent are seeking more foods that provide functional benefits (like added vitamins, fiber and gut health benefits), and 60% are seeking more protein-rich foods